Table 1.
Subgroups | EGFR+ | EGFR– | P-value |
---|---|---|---|
Cases | 34 | 33 | |
Age, mean ± SD | 53.0882 ± 8.1997 | 59.6061 ± 7.8020 | 0.023 |
Gender | <0.001 | ||
Males | 11 (32.35%) | 27 (81.82%) | |
Females | 23 (67.65%) | 6 (18.18%) | |
Smoking | <0.001 | ||
Yes | 8 (23.53%) | 26 (78.79%) | |
No | 26 (76.47%) | 7 (21.21%) | |
Pathological stages | 0.518 | ||
IIIb, IIIc | 15 (44.12%) | 12 (36.36%) | |
Iva, IVb | 19 (55.88%) | 21 (63.64%) | |
Histological types | <0.001 | ||
Adenocarcinoma | 32 (94.12%) | 14 (42.42%) | |
Squamous cell carcinoma | 2 (5.88%) | 19 (57.58%) | |
Rad_score (mean) | 4.167 | −3.947 | <0.001 |